Pangea Biomed

Pangea is redefining precision oncology and increasing the number of patients who can benefit from it. Immunotherapy and precision oncology have been around for decades, providing hope for those with cancer, but less than 10 percent of cancer patients benefit from todays treatments. By coupling the hidden power of RNA sequencing with ML-enabled network effects, our ENLIGHT platform can surface relevant biological insights to pinpoint the best path forward toward combating a patients cancer

Pangea biomed operates in the Biotechnology research industry.

Pangea biomed's revenue is 11m - 100m

Pangea biomed has 11 - 50 employees.